Cargando…

Management of mycophenolate mofetil-induced acne in patients with Systemic Lupus Erythematosus: report of four cases and review of the literature

BACKGROUND: Mycophenolate mofetil (MMF) is an immunosuppressive drug currently used to treat Systemic Lupus Erythematosus (SLE). In addition to clinical efficacy, MMF use is also supported by a favorable profile of tolerance, with main side effects being nausea, diarrhea, headache, and, less frequen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perricone, Carlo, Ceccarelli, Fulvia, Spinelli, Francesca Romana, Truglia, Simona, Priori, Roberta, Valesini, Guido, Conti, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045945/ https://www.ncbi.nlm.nih.gov/pubmed/32185330 http://dx.doi.org/10.31138/mjr.29.4.217

Ejemplares similares

Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort
por: Fabrizio, Conti, et al.
Publicado: (2015)

The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus
por: Ceccarelli, Fulvia, et al.
Publicado: (2014)

Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study
por: Conti, Fabrizio, et al.
Publicado: (2012)

Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices
por: Conti, Fabrizio, et al.
Publicado: (2013)

Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study
por: Ceccarelli, Fulvia, et al.
Publicado: (2018)

Kidney Expression of Toll Like Receptors in Lupus Nephritis: Quantification and Clinicopathological Correlations
por: Conti, Fabrizio, et al.
Publicado: (2016)

Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study
por: Ceccarelli, Fulvia, et al.
Publicado: (2019)

Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype
por: Ceccarelli, Fulvia, et al.
Publicado: (2015)

Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage
por: Conti, Fabrizio, et al.
Publicado: (2012)

Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus
por: Conti, Fabrizio, et al.
Publicado: (2016)

Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus
por: Ceccarelli, Fulvia, et al.
Publicado: (2018)

Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models
por: Ceccarelli, Fulvia, et al.
Publicado: (2017)

Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models
por: Ceccarelli, Fulvia, et al.
Publicado: (2018)

Correction: Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models
por: Ceccarelli, Fulvia, et al.
Publicado: (2019)

Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
por: Colasanti, Tania, et al.
Publicado: (2022)

Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010)

Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008)

Mycophenolate Mofetil for Systemic Lupus Erythematosus: Our 20-Year Experience
por: Trevisonno, Michael, et al.
Publicado: (2023)

Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype
por: Ceccarelli, Fulvia, et al.
Publicado: (2019)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Bullous Systemic Lupus Erythematosus Successfully Treated With Intravenous Immunoglobulin and Mycophenolate Mofetil
por: Chow, Kevin W, et al.
Publicado: (2023)

The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients
por: Ceccarelli, Fulvia, et al.
Publicado: (2022)

The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus
por: Scrivo, Rossana, et al.
Publicado: (2017)

Successful Treatment of Refractory Thrombocytopenia with Mycophenolate Mofetil in a Patient with Systemic Lupus Erythematosus
por: Chang, Hyun Kyu
Publicado: (2005)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
por: Hyun, Jae-Eun, et al.
Publicado: (2021)

B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus
por: Spinelli, Francesca Romana, et al.
Publicado: (2019)

Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
por: Spinelli, Francesca Romana, et al.
Publicado: (2023)

TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis
por: Barbati, Cristiana, et al.
Publicado: (2018)

The Impact of Caffeine Intake on Patients with Systemic Lupus Erythematosus: Protect Yourself, Drink More Coffee!
por: Orefice, Valeria, et al.
Publicado: (2020)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
por: Fassbinder, Till, et al.
Publicado: (2015)

Development and validation of limited sampling strategy equation for mycophenolate mofetil in children with systemic lupus erythematosus
por: Prabha, R., et al.
Publicado: (2016)

High Fat Diet, Metabolic Syndrome and Systemic Lupus Erythematosus: A Causal Loop
por: Perricone, Carlo, et al.
Publicado: (2020)

Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension
por: Machireddy, Kirthi, et al.
Publicado: (2018)

Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies
por: Conti, Fabrizio, et al.
Publicado: (2004)

Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases
por: Pecani, Arbi, et al.
Publicado: (2016)

Erratum to: Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases
por: Pecani, Arbi, et al.
Publicado: (2016)

Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome
por: Manganelli, Valeria, et al.
Publicado: (2019)

The Effect of Mycophenolate Mofetil on Non-Renal Manifestations in Systemic Lupus Erythematosus: Results from Korean Lupus Network Registry
por: Jung, Ui Hong, et al.
Publicado: (2019)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djpsgffqa4m26kpdtuhov2qsu3